NeuroMetrix Other Long-Term Assets 2010-2024 | NURO
NeuroMetrix Annual Other Long-Term Assets (Millions of US $) |
|
---|---|
2024 | $0 |
2023 | $0 |
2022 | $0 |
2021 | $0 |
2020 | $0 |
2019 | $0 |
2018 | $0 |
2017 | $0 |
2016 | $0 |
2015 | $0 |
2014 | $0 |
2013 | $0 |
2012 | $0 |
2011 | $0 |
2010 | $0 |
2009 | $0 |
NeuroMetrix Quarterly Other Long-Term Assets (Millions of US $) |
|
---|---|
2024-12-31 | |
2024-09-30 | $0 |
2024-06-30 | $0 |
2024-03-31 | $0 |
2023-12-31 | $0 |
2023-09-30 | $0 |
2023-06-30 | $0 |
2023-03-31 | $0 |
2022-12-31 | $0 |
2022-09-30 | $0 |
2022-06-30 | $0 |
2022-03-31 | $0 |
2021-12-31 | $0 |
2021-09-30 | $0 |
2021-06-30 | $0 |
2021-03-31 | $0 |
2020-12-31 | $0 |
2020-09-30 | $0 |
2020-06-30 | $0 |
2020-03-31 | $0 |
2019-12-31 | $0 |
2019-09-30 | $0 |
2019-06-30 | $0 |
2019-03-31 | $0 |
2018-12-31 | $0 |
2018-09-30 | $0 |
2018-06-30 | $0 |
2018-03-31 | $0 |
2017-12-31 | $0 |
2017-09-30 | $0 |
2017-06-30 | $0 |
2017-03-31 | $0 |
2016-12-31 | $0 |
2016-09-30 | $0 |
2016-06-30 | $0 |
2016-03-31 | $0 |
2015-12-31 | $0 |
2015-09-30 | $0 |
2015-06-30 | $0 |
2015-03-31 | $0 |
2014-12-31 | $0 |
2014-09-30 | $0 |
2014-06-30 | $0 |
2014-03-31 | $0 |
2013-12-31 | $0 |
2013-09-30 | |
2013-06-30 | |
2013-03-31 | |
2012-12-31 | $0 |
2012-09-30 | |
2012-06-30 | |
2012-03-31 | $0 |
2011-12-31 | $0 |
2011-09-30 | $0 |
2011-06-30 | $0 |
2011-03-31 | $0 |
2010-12-31 | $0 |
2010-09-30 | $0 |
2010-06-30 | $0 |
2010-03-31 | $0 |
2009-12-31 | $0 |
2009-09-30 | $0 |
2009-06-30 | $0 |
2009-03-31 | $1 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED PRODUCTS | $0.009B | $0.003B |
Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders. |